Alex Bajamonde

Medicine · Health Sciences

7h-index13.0kcitations8works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Renal cell carcinoma treatment(3), Cancer Immunotherapy and Biomarkers(2), Bladder and Urothelial Cancer Treatments(2), HER2/EGFR in Cancer Research(2), Monoclonal and Polyclonal Antibodies Research(2)

Publications8 total

Making Independence Work: Monitoring the Bevacizumab Colorectal Cancer Clinical Trial
2006
Determination of HER2 Gene Amplification by Fluorescence In situ Hybridization and Concordance with the Clinical Trials Immunohistochemical Assay in Women with Metastatic Breast Cancer Evaluated for Treatment with Trastuzumab
Breast Cancer Research and Treatment·2005· 212 cited
Targeted Therapy: Wave of the Future
Journal of Clinical Oncology·2005· 57 citedOpen Access
The VIVA Trial
Circulation·2003· 1.0k cited
Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2
New England Journal of Medicine·2001· 11.4k citedOpen Access
Interferon Gamma-1b Compared With Placebo in Metastatic Renal-Cell Carcinoma
The Journal of Urology·1999· 15 cited
The treatment of metastatic renal cell carcinoma patients with recombinant human gamma interferon.
PubMed·1998· 21 cited
Interferon Gamma-1b Compared with Placebo in Metastatic Renal-Cell Carcinoma
New England Journal of Medicine·1998· 311 citedOpen Access

Frequent Co-authors

Virginia Paton(4), Mark D. Pegram(2), Yves Fradet(2), Ian D. Davis(2), Peter Venner(2), Fred Saad(2), Malcolm J. Moore(2), Dennis J. Slamon(1), Brian Leyland‐Jones(1), Steven Shak(1), H. Fuchs(1), Thomas Fleming(1), W. Eiermann(1), Janet Wolter(1), José Baselga(1), Larry Norton(1), Timothy D. Henry(1), Brian H. Annex(1), George R. McKendall(1), Michael Azrin(1)